Surgical Stapling Devices Market Research Report and Outlook by 2028

The market for surgical stapling devices is projected to grow significantly, reaching approximately US$ 7,747.1 million by 2028, up from US$ 4,795.8 million in 2022, reflecting a compound annual growth rate (CAGR) of 8.3% from 2022 to 2028.

The growth of the surgical stapling devices market is primarily driven by an increase in the number of surgical procedures and wounds, alongside the introduction of new products and strategic partnerships. However, challenges such as rising product recalls and the high costs associated with surgical stapling devices are impeding market expansion.
The surge in surgical procedures performed in hospitals has prompted manufacturers of medical devices to innovate and launch new products while securing necessary regulatory approvals. Leading companies in the surgical stapling devices sector invest heavily in research and development to introduce advanced offerings. Below are some notable recent developments and product launches in this market.
In October 2022, Teleflex Incorporated finalized its acquisition of Standard Bariatrics, Inc., which has developed a cutting-edge powered stapling technology specifically for bariatric surgery. The acquisition was valued at US$ 170 million at closing, with potential additional payments of up to US$ 130 million contingent on achieving specific commercial milestones.
In June 2022, Ethicon, a subsidiary of Johnson & Johnson MedTech, introduced the ECHELON 3000 Stapler in the United States. This digitally enabled device allows surgeons to perform one-handed powered articulation, catering to the unique requirements of their patients. With a jaw aperture that is 39% larger and an articulation span that is 27% greater, the ECHELON 3000 enhances access and control during transections, even in confined spaces and on challenging tissues. The device is also equipped with software that provides real-time haptic and audible feedback, enabling surgeons to make critical adjustments during procedures.
In October 2021, Hologic, Inc. entered into a definitive agreement to acquire Bolder Surgical for approximately US$ 160 million, subject to customary closing adjustments. Hologic, a leader in women's health, aims to expand its surgical portfolio by incorporating Bolder's advanced energy vessel sealing devices, which are utilized in laparoscopic surgeries.

In August 2021, Panther Healthcare launched the Smart Powered Stapler platform, which offers intelligent and automatic control over tissue compression, transection, and resection for various surgical procedures, including gastrointestinal, thoracic, colorectal, oncology, gynecologic, and other laparoscopic surgeries. This device has been made available in regions including Europe, the Middle East & Africa, Asia, and Latin America.
In June 2021, Intuitive introduced India's first robotic-assisted surgical stapler, SureForm, which features SmartFire technology. This integrated software can take over 1,000 measurements per second, automatically adjusting the firing process during stapling to ensure a consistent staple line and minimize tissue damage across varying tissue thicknesses.
In November 2020, Dolphin launched DURAMATE, a reloadable, reusable, autoclavable, and cost-effective surgical skin stapler in India. This high-quality, multiple-use skin stapler is a ready-to-use sterile device designed ergonomically and manufactured in collaboration with US experts. It is suitable for skin closure in a variety of surgical procedures, including abdominal, gynecological, orthopedic, and thoracic surgeries.
In September 2019, Ethicon released the Echelon Circular Powered Stapler, designed to mitigate complications associated with colorectal, gastric, and thoracic surgeries. This innovative product combines two of Ethicon's technologies: 3D Stapling Technology, which evenly distributes compression, and Gripping Surface Technology, which facilitates gentler handling to reduce compressive forces on tissues.
The continuous introduction of innovative products, along with strategic acquisitions and collaborations, is propelling the growth of the surgical stapling devices market.
Type Insights - Surgical Stapling Devices Market
The surgical stapling devices market is categorized by type into disposable and reusable surgical staplers. The disposable surgical staplers segment dominated the market in 2022 and is expected to exhibit a higher CAGR during the forecast period (2022-2028). Disposable devices are typically made from medical-grade plastic, while reusable devices are constructed from stainless steel for biomedical applications. Disposable circular suture devices serve as alternatives to manual suturing during surgeries, operating on the principle of using titanium staples for tissue anastomosis, similar to a stapling machine. Advances in technology and production processes have led to the development of reliable, user-friendly disposable circular anastomoses that offer quick suturing with minimal side effects. Many laparoscopic staple cartridges are designed to change direction, enhancing flexibility in confined operating spaces, and include safety features to prevent the accidental firing of used cartridges, ensuring safe operation.
The Centers for Disease Control and Prevention (CDC) advocates for the use of disposable devices and has established protocols to mitigate the spread of pathogens. Regulatory bodies like the US Food and Drug Administration (FDA) have also implemented measures to ensure strict adherence to sterilization protocols for medical devices to prevent infections.

Application Insights - Surgical Stapling Devices Market

The global surgical stapling devices market is segmented by application into orthopedic surgery, endoscopic surgery, cardiac and thoracic surgery, abdominal and pelvic surgery, and others. The orthopedic surgery segment held the largest market share in 2022 and is projected to grow at the highest CAGR during the forecast period. Surgical staples are now essential in modern surgery, often preferred over traditional suturing methods, especially for larger incisions. For example, Ethicon's next-generation Echelon 3000 Stapler is designed to staple and transect various tissue types in both open and minimally invasive surgical procedures, featuring a 27% larger articulation span and a 39% larger jaw aperture.
According to the Canadian Joint Replacement Registry (CJRR), over 63,000 hip replacements and 75,000 knee replacements were performed in Canada during 2019-2020, with infection, aseptic loosening, and instability being the top three reasons for revisions. The average inpatient cost for hip and knee replacements was approximately US$ 10,500, while revision surgeries averaged around US$ 16,800. Additionally, there is a notably higher risk of wound infection associated with staple closure compared to sutures after orthopedic surgeries. Bone staples, made from surgical-grade stainless steel or titanium, are thicker and stronger. For instance, MedShape Inc. has launched the DynaClip Bone Fixation system, utilizing superelastic nickel-titanium (NiTiNOL) technology, representing a new generation in bone stapling that provides dynamic compression and durability for demanding conditions in foot and ankle surgeries. Furthermore, Tyber Medical has received FDA 510(k) clearance for its new NiTy+ One-Shot staple fixation system.